Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 1/18/2013

January 18, 2013 – As a federal court in Missouri prepares to start trials for more than 1,000 NuvaRing lawsuits filed by women and families over blood clot injuries, news came this week of a new study which may add to the health warnings of the contraceptive.

NuvaRing, which is made by Merck, is a small plastic vaginal ring which is implanted once per month to prevent pregnancy. Although the manufacturer has marketed it as a lower-hormone alternative, experts point out that the constant and direct absorption of hormones into the bloodstream from the device may result in higher overall doses than traditional pills.

DrugRisk previously warned that studies have linked contraceptives like NuvaRing to higher blood clot risks than traditional birth control pills.

In May of 2012, the British Medical Journal published research from Denmark which linked vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. In June, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could result in a 2.5 to 3-fold increased risk of blood clots.

Now, a study from Brigham and Women’s Faulkner Hospital in Boston has discovered that the risks of blood clots for women using combined hormone vaginal ring contraceptives like NuvaRing are even higher for those suffering migraines.*

Blood clots can cause extremely dangerous conditions such as pulmonary embolism, deep vein thrombosis and stroke. They can also result in significant hospital treatment, follow-up care, expensive medical bills and lost earnings.

Due to the number of women who have already filed a NuvaRing lawsuit over blood clots, cases from around the country have been consolidated to a federal Multi-District Litigation court in Missouri.

With the latest warnings for those suffering from migraines, the number of women affected could rise even further. However, the time to file a claim is limited.

If you or a loved one suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing, it is recommended that you speak with a lawyer about your legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, contact us today.